29 June 2021 : Case report
A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab
Unusual or unexpected effect of treatment, Adverse events of drug therapy
Sonya K. Kedzior12EF, Gabrielle Jacknin2E, Andi Hudler3E, Scott W. Mueller12E, Tyree Heath Kiser 12ACDEG*DOI: 10.12659/AJCR.931702
Am J Case Rep 2021; 22:e931702